APA (7th ed.) Citation

Kastrin, M., Urbančič Rovan, V., & Frangež, I. (2021). Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot. Journal of clinical medicine, 10(6), 1208. https://doi.org/10.3390/jcm10061208

Chicago Style (17th ed.) Citation

Kastrin, Matevž, Vilma Urbančič Rovan, and Igor Frangež. "Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot." Journal of Clinical Medicine 10, no. 6 (2021): 1208. https://doi.org/10.3390/jcm10061208.

MLA (9th ed.) Citation

Kastrin, Matevž, et al. "Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot." Journal of Clinical Medicine, vol. 10, no. 6, 2021, p. 1208, https://doi.org/10.3390/jcm10061208.